ABSTRACT Vasodepressor mechanisms of adenosine were investigated in spinally-anesthetized dogs. An i.v.-infusion of adenosine (0.1-10 pmol/kg/min) caused a slowly developing and sustained decrease in blood pressure (BP). This vasodepression was antagonized by glibenclamide, a blocker of ATP-sen sitive K+ (KATP) channels. On the other hand, a transient decrease in BP caused by a single bolus i.v. injection of adenosine was not antagonized by glibenclamide in our previous study. These results sug gested that the opening of KATP channels is gradually recruited in the vasodepressor mechanisms for adenosine-induced sustained vasodepression.
It has been accepted that vasodilatation or vaso depression caused by adenosine is mediated by adeno sine A2-receptors (1, 2) and that an increase in cAMP plays an important role in this process (3, 4) . Recently, Belloni and Hintze (5) suggested that opening of ATP sensitive K+ (KATP) channels was involved in the vasodepressor response to adenosine in anesthetized dogs; the response was antagonized by glibenclamide, a blocker of KATP channels (6) . Our previous study, however, failed to demonstrate the involvement of KATP channels in the transient decrease in blood pres sure (BP) caused by a single bolus i.v.-injection in spinally-anesthetized dogs; the decrease in BP caused by the adenosine injection was not antagonized by glibenclamide (7) . On the other hand, the vasodepres sor response to YT-146, a selective adenosine A2-recep tor agonist (8, 9) , which developed slowly and was sus tained, was antagonized by glibenclamide in the same study (7) . Thus, it was hypothesized that the opening of KATP channels would be gradually recruited in the vasodepressor mechanism of adenosine-A2-receptor mediated vasodepression (7) . To test this hypothesis we investigated how the vasodepressor response to i.v.-in fusion of adenosine would be modified by glibencla mide.
Fourteen young mongrel dogs of either sex, weighing 7 to 14 kg, were anesthetized with sodium pentobarbital (30 mg/kg, i.v.). Spinal anesthesia was induced with an intra-cistemal injection of dibucaine hydrochloride solu tion (about 0.2 ml/kg) after i.v.-injection of nadolol (100,ug/kg) and atropine (1 mg/kg). Bilateral vago tomy was performed. Animals were respired with room air in a tidal volume of 20 ml/kg at 18 breaths/min by the use of a respirator (Shinano, Model SN-480-3). Body temperature was maintained at about 39°C with a heating device. BP was measured at the right femoral artery with a pressure transducer (Statham, P-50) and heart rate (HR) was measured with a cardiotachometer (San-ei, 1321) triggered by arterial pressure pulses.
The BP of spinally-anesthetized animals was main tained at an elevated level by i.v.-infusion of noradrena line (0.5 mg/kg/min) by the use of an infusion pump (Harvard Apparatus, Model 600-00). Five animals were given the vehicle (100% N,N-dimethylformamide, con trol), another five glibenclamide, and an additional four glibenclamide plus theophylline. Before receiving adeno sine infusion, all the animals were given dipyrida mole (100,ug/kg, i.v.), a potentiator of adenosine (10) . Otherwise, i.v.-infusions of adenosine failed to produce sizable decreases in BP. An infusion pump (Terumo, STC-521) was used for the continuous i.v.-infusion of adenosine. Infusion rates were increased when the BP responses reached a nadir.
Glibenclamide (Yamanouchi), nadolol (Squibb), adeno sine (Sigma), theophylline (Sigma), (-)-noradrenaline base (Sigma), dibucaine hydrochloride (0.3% hyper baric solution in ampoules, Teikoku Chemical) and atropine sulfate (Wako) were used. Glibenclamide was dissolved in 0.5 ml of 100% N, N-dimethylformamide at the desired concentrations. Nadolol and (-)-nor adrenaline base were dissolved in 0.1 N HCI. Other compounds were dissolved and diluted with 0.9% saline to the desired concentrations. Changes in MBP were expressed as percentages of its basal values obtained before infusion of adenosine. ED50 values for adenosine were obtained by computer fitting of the dose-response curves for the change in MBP to a sigmoid function by a non-linear least squares routine. The statistical significance of differ ences between ED50 values was analyzed with Student's t-test. A P value smaller than 0.05 was considered to in dicate a significant difference.
The average values of MBP and HR for fourteen spinally-anesthetized dogs, whose MBPs were main tained at an elevated level with i.v.-infusion of nor adrenaline, were 176 ± 4 mmHg and 149 ± 6 beats/min, respectively. Glibenclamide or theophylline per se had no effect on MBP and HR.
In control dogs, infusion of adenosine (0.1-10 ,umol/kg/min) caused slowly developing decreases in BP and HR, and MBP was lowered to about 46 mmHg and HR to 116 beats/min at the highest infusion rate (10,umol/kg/min). One of such experiments is shown in Fig. 1 , and the dose-response curve for the decrease in MBP is shown in Fig. 2 . In dogs that received glibenclamide (6,umol /kg, i.v.) , the dose-response curve for the decrease in MBP underwent a rightward shift (Fig. 2) ; the ED50 value increased about 6-fold (1.3 to 7.5,umol/kg/min). A further rightward shift of the dose-response curve for the decrease in MBP oc curred in dogs that received glibenclamide (6 ,umol/kg, i.v.) plus theophylline (30 ,umol/kg, i.v.) (Fig. 2) ; the ED50 value increased about 33-fold (1.3 to 42.6 ,umol/kg/min). Decreases in HR to adenosine infusion remained virtually unchanged by glibenclamide or glibenclamide plus theophylline.
The slowly developing and sustained vasodepressor responses to i.v.-infusions of adenosine described above were very similar to those caused by a single bolus i.v. injection of YT-146 in time course and in being antago nized by 6 ,umol/kg, i.v. of glibenclamide (7) . In the previous study (7), the transient vasodepressor re sponses to single bolus i.v.-injections of adenosine were not antagonized by the same dose of glibenclamide. Thus, as hypothesized previously (7), the vasodepressor mechanisms for adenosine-A2-receptor-mediated vaso depression likely differ between the transient response and the slowly developing response. At least in the dog, the opening of KATP channels appears to be gradually recruited to the vasodepressor mechanisms. The approximately 6-fold increase in ED50 value for adenosine caused by glibenclamide in the present ex periments was very close to the 5.5-fold increase in ED50 value for YT-146 under similar conditions in the previous study (7) . However, the approximately 33-fold increase in ED50 value of adenosine caused by glibenclamide plus theophylline was much greater than the 6.8-fold increase in ED50 value of YT-146 that had occurred under similar conditions in the previous study (7) . This suggests that the vasodepressor response to i.v.-infusion of adenosine, which is nonselective for adenosine Al and A2 receptors, may involve more com plicated vasodepressor mechanisms than that to the selective adenosine A2-receptor agonist YT-146. Adeno sine has been shown to exert its vasodilator effect by stimulation of A1-receptors, which are linked to guanyl ate cyclase (11) , in addition to an action via adenosine A2-receptors. 
